These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30027496)

  • 1. Dopamine, time perception, and future time perspective.
    Mitchell JM; Weinstein D; Vega T; Kayser AS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2783-2793. PubMed ID: 30027496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing dopamine tone modulates global and local cortical perfusion as a function of COMT val158met genotype.
    Furman DJ; Pappas I; White RL; Kayser AS; D'Esposito M
    Neuroimage; 2021 Nov; 242():118472. PubMed ID: 34390874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone.
    Schacht JP; Yeongbin Im ; Hoffman M; Voronin KE; Book SW; Anton RF
    Neuropsychopharmacology; 2022 Oct; 47(11):1953-1960. PubMed ID: 35523943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tolcapone and bromocriptine on cognitive stability and flexibility.
    Cameron IGM; Wallace DL; Al-Zughoul A; Kayser AS; D'Esposito M
    Psychopharmacology (Berl); 2018 Apr; 235(4):1295-1305. PubMed ID: 29427081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catechol-O-methyltransferase inhibitor tolcapone modulates alcohol consumption and impulsive choice in alcohol use disorder.
    Coker AR; Weinstein DN; Vega TA; Miller CS; Kayser AS; Mitchell JM
    Psychopharmacology (Berl); 2020 Oct; 237(10):3139-3148. PubMed ID: 32617646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers.
    Kayser AS; Vega T; Weinstein D; Peters J; Mitchell JM
    Neuroimage Clin; 2017; 13():339-348. PubMed ID: 28066708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.
    Giakoumaki SG; Roussos P; Bitsios P
    Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study.
    Ashare RL; Wileyto EP; Ruparel K; Goelz PM; Hopson RD; Valdez JN; Gur RC; Loughead J; Lerman C
    Drug Alcohol Depend; 2013 Dec; 133(3):852-6. PubMed ID: 24095246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine, locus of control, and the exploration-exploitation tradeoff.
    Kayser AS; Mitchell JM; Weinstein D; Frank MJ
    Neuropsychopharmacology; 2015 Jan; 40(2):454-62. PubMed ID: 25074639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolcapone improves cognition and cortical information processing in normal human subjects.
    Apud JA; Mattay V; Chen J; Kolachana BS; Callicott JH; Rasetti R; Alce G; Iudicello JE; Akbar N; Egan MF; Goldberg TE; Weinberger DR
    Neuropsychopharmacology; 2007 May; 32(5):1011-20. PubMed ID: 17063156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of regional cerebral blood flow: An arterial spin labelling study of genetic and pharmacological manipulation of COMT activity.
    Martens M; McConnell FK; Filippini N; Mackay CE; Harrison PJ; Tunbridge EM
    Neuroimage; 2021 Jul; 234():117999. PubMed ID: 33789133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans.
    Ranganathan M; De Aquino JP; Cortes-Briones JA; Radhakrishnan R; Pittman B; Bhakta S; D'Souza DC
    Psychopharmacology (Berl); 2019 Nov; 236(11):3209-3219. PubMed ID: 31187152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.
    Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ
    Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions.
    Laatikainen LM; Sharp T; Harrison PJ; Tunbridge EM
    PLoS One; 2013; 8(4):e61839. PubMed ID: 23613951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers.
    Magalona SC; Rasetti R; Chen J; Chen Q; Gold I; Decot H; Callicott JH; Berman KF; Apud JA; Weinberger DR; Mattay VS
    CNS Drugs; 2013 Aug; 27(8):663-73. PubMed ID: 23794107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men.
    Valomon A; Holst SC; Borrello A; Weigend S; Müller T; Berger W; Sommerauer M; Baumann CR; Landolt HP
    Neuropsychopharmacology; 2018 Jun; 43(7):1599-1607. PubMed ID: 29472644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibility.
    Byers S; Buchler IP; DePasquale M; Rowley HL; Kulkarni RS; Pinder L; Kolobova A; Li C; Au V; Akuma D; Zhang G; Wei H; Cheetham SC; Barrow JC; Carr GV
    Psychopharmacology (Berl); 2020 Sep; 237(9):2695-2707. PubMed ID: 32474681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype.
    Furman DJ; White RL; Naskolnakorn J; Ye J; Kayser A; D'Esposito M
    J Cogn Neurosci; 2020 May; 32(5):804-821. PubMed ID: 31905090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
    Detrait ER; Carr GV; Weinberger DR; Lamberty Y
    Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase activity does not influence emotional processing in men.
    Martens MA; Dalton N; Scaife J; Harmer CJ; Harrison PJ; Tunbridge EM
    J Psychopharmacol; 2022 Jun; 36(6):768-775. PubMed ID: 35443830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.